谢操 - 复旦大学

个人简介

教育经历 1996.09 – 2000.7 上海医科大学药学院药物化学专业本科 2003.09 – 2005.06 复旦大学药学院药剂学专业硕士 2005.09 – 2014.12 复旦大学药学院药剂学专业博士工作经历 2000.07 – 至今复旦大学药学院，讲师 2004.08 – 2004.11 美国马里兰大学,访问学者

研究领域

主动靶向递药系统的研究

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Wang J, Lei Y,Xie C, Lu W, Wagner E, Xie Z, Gao J, Zhang X, Yan Z, Liu M*.Retro-InversoCendR Peptide-Mediated Polyethyleneimine for Intracranial Glioblastoma-Targeting Gene Therapy. BioconjugChem, 25(2):414-423, 2014 Yan Z, Yang Y, Wei X, Zhong J, Wei D, Liu L, Xie C, Wang F, Zhang L, Lu W*, He D.Tumor-penetrating peptide mediation: an effective strategy for improving the transport of liposomes in tumor tissue.Mol Pharm, 11(1):218-225, 2014 Wang J, Lei Y, Xie C, Lu W, Yan Z, Gao J, Xie Z, Zhang X, Liu M*.Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex.Int J Pharm, 458(1):48-56, 2013 Lei Y, Wang J, Xie C, Wagner E, Lu W, Li Y, Wei X, Dong J, Liu M*.Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery. J Gene Med, 15(8-9):291-305, 2013 Yang Y, Yan Z, Wei D, Zhong J, Liu L, Zhang L, Wang F, Wei X, Xie C, Lu W*, He D*.Tumor-penetrating peptide functionalization enhances the anti-glioblastoma effect of doxorubicin liposomes. Nanotechnology, 24(40):405101, 2013 Liu X, Liu C, Zhang W, Xie C, Wei G*, Lu W.Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin.Int J Pharm, 448(1):159-167, 2013 Li Y, Lei Y, Wagner E, Xie C, Lu W, Zhu J, Shen J, Wang J, Liu M*.Potent retro-inverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells.BioconjugChem, 24(1):133-143, 2013 Li F, Li QH, Wang JY*, Zhan CY, Xie C, Lu WY. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats. J Control Release, 159(2):261-270, 2012 Yan Z, Wang F, Wen Z, Zhan C, Feng L, Liu Y, Wei X, Xie C, Lu W*.LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor. J Control Release, 157(1):118-125, 2012